Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes

Olof Eriksson; Irina Velikyan; Torsten Haack; Martin Bossart; Iina Laitinen; Philip J. Larsen; Jan Erik Berglund; Gunnar Antoni; Lars Johansson; Stefan Pierrou; Joachim Tillner; Michael Wagner

doi:10.2967/jnumed.121.262506

Research ArticleClinical Investigation

Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes

Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner

Journal of Nuclear Medicine May 2022, 63 (5) 794-800; DOI: https://doi.org/10.2967/jnumed.121.262506

Olof Eriksson

1Antaros Medical AB, Uppsala, Sweden;

2Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irina Velikyan

3Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;

4Akademiska Sjukhuset, Uppsala, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Torsten Haack

5R&D Research Platform, Integrated Drug Discovery, Sanofi, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Bossart

5R&D Research Platform, Integrated Drug Discovery, Sanofi, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Iina Laitinen

6Global Imaging, Sanofi, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philip J. Larsen

7Diabetes Research, Sanofi, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan Erik Berglund

8Clinical Trial Consultants AB, Uppsala, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gunnar Antoni

3Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;

4Akademiska Sjukhuset, Uppsala, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lars Johansson

1Antaros Medical AB, Uppsala, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stefan Pierrou

1Antaros Medical AB, Uppsala, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joachim Tillner

9Translational Medicine, Sanofi, Frankfurt, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Wagner

5R&D Research Platform, Integrated Drug Discovery, Sanofi, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue 5

May 1, 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes

Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner, Michael Wagner

Journal of Nuclear Medicine May 2022, 63 (5) 794-800; DOI: 10.2967/jnumed.121.262506

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes

Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner, Michael Wagner

Journal of Nuclear Medicine May 2022, 63 (5) 794-800; DOI: 10.2967/jnumed.121.262506

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

GLP1R
PET
exendin
type 2 diabetes
β-cell mass

Main menu

User menu

Search

Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords